Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors

Patients with nonresectable metastatic neuroendocrine tumors (NETs) experience symptoms of hormone hypersecretion including diarrhea, flushing, and bronchoconstriction, which can interfere with quality of life [Anthony and Vinik (2011) Pancreas, 40:987]. Treatment with a long-acting release formulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Efraij, Khalid, Aljama, Mohammed A, Kennecke, Hagen Fritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472209/
https://www.ncbi.nlm.nih.gov/pubmed/25727756
http://dx.doi.org/10.1002/cam4.435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472209/
https://www.ncbi.nlm.nih.gov/pubmed/25727756
http://dx.doi.org/10.1002/cam4.435

Ejemplares similares